Skip to the main content.

Newsroom

Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company

Extension reinforces KBI’s commitment to forge long-term partnerships to successfully address complex clinical development and commercialization challenges. Durham, North Carolina (July 23, 2024) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences...

Read More

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

Durham, North Carolina (April 15, 2024) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and...

Read More

KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer

Durham, North Carolina (April 1, 2024) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing...

Read More

KBI Biopharma Recognized as a Leader in All Six Categories of the 2024 CDMO Leadership Awards

KBI Biopharma, a JSR Life Sciences Company and leading global Contract Development and Manufacturing Organization (CDMO) has received six awards in...

Read More

KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions

Alliance combines strengths of both companies resulting in end-to-end offering for efficient and seamless biopharmaceutical development and cGMP...

Read More

KBI Biopharma, Inc. Appoints Maggie Chen as Site Head of Patriot Park Mammalian cGMP Manufacturing Facility

Durham, North Carolina (December 5, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the recent appointment of Maggie...

Read More

KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing

Offering extends legacy of SUREtechnology Platform™ for more efficient workflows and simplified processes. Durham, North Carolina (September 12,...

Read More

KBI Biopharma Continues to Strengthen Leadership and Expertise With Key Executive Appointments

Durham, North Carolina (August 10, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments...

Read More

KBI's Aaron Pilling Discusses the KBI PUREplatform Launch at BIO International 2023

KBI's PUREplatform™ is a game-changing microbial expression offering that redefines biopharmaceutical manufacturing. The platform leverages the...

Read More

KBI's Leadership Team Discusses Operational Consolidation with Selexis at BIO International 2023

The recent operational consolidation of KBI Biopharma, Inc. and Selexis SA brings a streamlined approach to support customers in rapidly accelerating...

Read More

Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.